TAM
ARKG icon

Titleist Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Titleist Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Hold
8,350
– – 0.02% 328
2026
Q1 		$221K Hold
8,350
– – 0.02% 383
2025
Q4 		$242K Hold
8,350
– – 0.02% 347
2025
Q3 		$232K Sell
8,350
-450
-5% -$11.4K 0.02% 289
2025
Q2 		$214K Buy
+8,800
New +$193K 0.02% 300
2025
Q1 		– Sell
-11,975
Closed -$282K – 299
2024
Q4 		$282K Sell
11,975
-4,600
-28% -$113K 0.03% 259
2024
Q3 		$424K Sell
16,575
-300
-2% -$7.64K 0.06% 189
2024
Q2 		$396K Hold
16,875
– – 0.06% 187
2024
Q1 		$485K Buy
16,875
+10,275
+156% +$309K 0.09% 154
2023
Q4 		$217K Buy
+6,600
New +$179K 0.04% 206

Other funds holding ARKG

MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
CFIM
Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
GVCM
Global View Capital Management Waukesha, Wisconsin $484M AUM 48.46% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

Titleist Asset Management's ARKG Position: Q2 2026 in Review

Titleist Asset Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 8,350 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #328.

Titleist Asset Management first reported a position in ARKG in Q4 2023 and has held it in 10 quarters since. The position peaked at $485K in Q1 2024. 71 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Titleist Asset Management held 8,350 shares of ARK Genomic Revolution ETF worth $351K as of Q2 2026.
  • Titleist Asset Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.02% of Titleist Asset Management's portfolio in Q2 2026, its #328 holding.
  • Titleist Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 10 quarters since.
  • Titleist Asset Management's ARK Genomic Revolution ETF position peaked at $485K in Q1 2024.
  • 71 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.